IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0720186
(2000-12-20)
|
우선권정보 |
US-US98/13449 (1998-06-29) |
국제출원번호 |
PCT/US99/14796
(1999-06-29)
|
국제공개번호 |
WO00/00146
(2000-01-06)
|
발명자
/ 주소 |
- Ehrnsperger, Bruno Johannes
- Schmidt, Mattias
- Schumann, Karl Michael
- Desai, Fred Naval
- Lavon, Gary Dean
- Young, Gerald Alfred
- Roe, Donald Carroll
|
출원인 / 주소 |
- The Procter & Gamble Company
|
대리인 / 주소 |
Fitzpatrick, Matthew P.Patel, Ken K.Miller, Steven W.
|
인용정보 |
피인용 횟수 :
10 인용 특허 :
15 |
초록
▼
The present invention is a liquid transport member with significantly improved liquid handling capability, which has at least one bulk or inner region with a high average permeability, completely circumscribed by a wall region. The wall region further comprises at least one port region with a lower
The present invention is a liquid transport member with significantly improved liquid handling capability, which has at least one bulk or inner region with a high average permeability, completely circumscribed by a wall region. The wall region further comprises at least one port region with a lower permeability than the inner region, and with a ratio of its permeability to its thickness of at least 10-7m.
대표청구항
▼
The present invention is a liquid transport member with significantly improved liquid handling capability, which has at least one bulk or inner region with a high average permeability, completely circumscribed by a wall region. The wall region further comprises at least one port region with a lower
The present invention is a liquid transport member with significantly improved liquid handling capability, which has at least one bulk or inner region with a high average permeability, completely circumscribed by a wall region. The wall region further comprises at least one port region with a lower permeability than the inner region, and with a ratio of its permeability to its thickness of at least 10-7m. e Inc., Page(s) 702-705. Joseph F. Sabik, MD, et al., Axillary Artery: An Alternative Site of Arterial Cannulation for Patients with Extensive Aortic and Peripheral Vascular Disease, .COPYRGT. 1995 by Mosby-Year Book, Inc., The Journal of Thoracic and Cardiovascular Surgery, pp. 886-891. Nicholas T. Kouchoukos, et al., Perfusion for Thoracic Aortic Surgery, Section V. Clinical Application and Management of CPB, pp. 636-654. syringe assembly comprises a needle free syringe assembly. 6. An injecting device, comprising: the medical injector assembly of claim 1; and a filling assembly that comprises: a cartridge housing configured for receiving a first end of a cartridge that has a chamber containing a medicament and first and second ends, the first end including a seal for sealing the medicament in the chamber, and the second end including a stopper sealingly disposed in the chamber; an adapter associated with the cartridge housing and configured for coupling the chamber to the syringe assembly for transferring the medicament to the fluid chamber; and a post associated with the cartridge housing in a post position from which movement towards the adapter is substantially prevented, wherein the post is configured such that positioning of the second end of the cartridge in a first position with respect to the post and of the post in the post position causes the post to displace the stopper towards the seal by an amount sufficient to reduce or eliminate adhesion between the chamber and the stopper for permitting filling of the fluid chamber from the chamber and for substantially preventing said movement of the cartridge past the first position. 7. The injecting device of claim 6, wherein the post is configured such that movement to the first position is insufficient to expel a substantial amount of the medicament from the chamber with the seal opened by the opening member. 8. The injecting device of claim 6, further comprising a cap having an engaged association with the cartridge housing in an engaged position from which movement therebetween past the engaged position towards the adapter is substantially prevented, wherein the post extends from the cap in the post position and the cap is configured for substantially preventing said movement of the cartridge past the first position. 9. The injecting device of claim 8, wherein the cap is configured and dimensioned for receiving the second end of the cartridge such that movement of the second end into the cap causes the post to displace the stopper towards the seal by said amount sufficient to reduce or eliminate adhesion between the chamber and the stopper. 10. The injecting device of claim 8, wherein the cap and the adapter housing are configured such that the engagement thereof causes sufficient displacement of the stopper for purging an amount of any air contained in the cartridge with the seal opened prior to the attachment to the syringe assembly. 11. The injecting device of claim 6, wherein the post is disposed and configured such that the engagement of the cap with the adapter housing causes the post to move the seal to the first position. 12. The injecting device of claim 6, wherein the adapter comprises a cartridge opening member configured for opening the seal to permit extraction of the medicament therefrom. 13. The injecting device of claim 12, wherein the adapter comprises a needle disposed and configured for penetrating the seal for said opening of the seal. 14. The injecting device of claim 6, wherein the adapter comprises a wall that defines a wall opening in fluid communication with the cartridge opening member to create a pathway for drawing the medicament out of the chamber. 15. The injecting device of claim 6, wherein the adapter is configured for connecting the cartridge to the syringe assembly to allow the medicament to flow from the chamber into the fluid chamber. 16. The injecting device of claim 6, wherein the adapter is configured for engaging the first end of the cartridge. 17. The injecting device of claim 16, wherein the adapter comprises a frangible retaining member configured for engaging and retaining the first end of the cartridge and for breaking upon removal of the cartridge from the adapter housing for inhibiting repeat uses of the filling assembly. 18. The injecting device of claim 17, wherein the frangible retaining member comprised a plurality of resilien
※ AI-Helper는 부적절한 답변을 할 수 있습니다.